Yolk antibody composition to prevent and treat pathogenesis of Helicobacter pylori, Porphyromonas gingivilis and Streptococcus mutans, product prepared with yolk antibody composition and application of yolk antibody composition
A technology of Helicobacter pylori and Streptococcus mutans, which is applied to medical preparations with non-active ingredients, medical preparations containing active ingredients, antibodies, etc., which can solve the problems of increasing drug resistance of oral bacteria, recurrent disease, and damage to the oral environment, etc. problems, to achieve the effect of preventing gastric diseases and cardiovascular system diseases, increasing the body's antibacterial, and increasing drug resistance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0052] Example 1 Yolk antibody composition for preventing and curing Helicobacter pylori, Porphyria gingivalis and Streptococcus mutans
[0053] The egg yolk antibody composition for preventing and curing Helicobacter pylori, Porphyromonas gingivalis and Streptococcus mutans by mass includes the following components: 2 parts of Streptococcus mutans egg yolk antibody, 2.5 parts of Porphyromonas gingivalis egg yolk antibody, Helicobacter pylori 2 copies of bacterial egg yolk antibody.
Embodiment 2
[0054] Example 2 Yolk antibody composition for preventing and curing Helicobacter pylori, Porphyria gingivalis and Streptococcus mutans
[0055] The egg yolk antibody composition for preventing and treating Helicobacter pylori, Porphyromonas gingivalis and Streptococcus mutans in parts by mass includes the following components: 5 parts of Streptococcus mutans yolk antibody, 1 part of Porphyromonas gingivalis yolk antibody, Helicobacter pylori 4 copies of bacterial egg yolk antibody.
Embodiment 3
[0056] Example 3 Lozenges
[0057] 1 part of egg yolk antibody composition for preventing and curing Helicobacter pylori, Porphyria gingivalis and Streptococcus mutans, 3 parts of sorbitol, 0.2 part of aspartame, 95.8 parts of medicinal excipients, low-temperature granulation of the above-mentioned tablet medicine, and then Press into lozenges of different shapes, 2 grams each.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com